[1]
Kanar Muthanna Alawad, Monther Faisal Mahdi and Ayad M.R. Raauf 2022. Molecular Docking study, and In vitro Evaluation of Antitumor Activity of Some New Isoxazoline and Pyrazoline Derivatives of Nabumetone against breast cancer cell line (MCF-7). Al Mustansiriyah Journal of Pharmaceutical Sciences. 22, 3 (Oct. 2022), 24–34. DOI:https://doi.org/10.32947/ajps.v22i3.886.